Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 145.61%30.4K | 17.07%11.48K | 5.37%11.78K | 97.87%44.38K | 10.24%11.02K | 141.35%12.38K | 127.70%9.81K | 272.54%11.18K | 154.63%22.43K | 209.76%9.99K |
| Gross profit | -145.61%-30.4K | -17.07%-11.48K | -5.37%-11.78K | -97.87%-44.38K | -10.24%-11.02K | -141.35%-12.38K | -127.70%-9.81K | -272.54%-11.18K | -154.63%-22.43K | -209.76%-9.99K |
| Operating expense | 88.96%11.21M | 51.05%9.66M | 34.09%6.75M | 22.63%23.79M | -1.17%6.43M | 10.54%5.93M | 43.96%6.39M | 63.20%5.03M | 18.25%19.4M | 61.93%6.51M |
| Selling and administrative expenses | 68.67%2.42M | 83.51%2.22M | 58.26%1.89M | 8.33%5.72M | -4.80%1.89M | 13.35%1.43M | 21.53%1.21M | 14.57%1.19M | 3.18%5.28M | 44.85%1.98M |
| -General and administrative expense | 68.67%2.42M | 83.51%2.22M | 58.26%1.89M | 8.33%5.72M | -4.80%1.89M | 13.35%1.43M | 21.53%1.21M | 14.57%1.19M | 3.18%5.28M | 44.85%1.98M |
| Depreciation amortization depletion | ---- | 17.07%11.48K | ---- | ---- | ---- | 141.35%12.38K | 127.70%9.81K | ---- | ---- | ---- |
| -Depreciation and amortization | ---- | 17.07%11.48K | ---- | ---- | ---- | 141.35%12.38K | 127.70%9.81K | ---- | ---- | ---- |
| Other operating expenses | 95.42%8.79M | 43.46%7.43M | 26.58%4.86M | 27.99%18.06M | 0.42%4.54M | 9.68%4.5M | 50.46%5.18M | 87.97%3.84M | 25.10%14.11M | 70.73%4.53M |
| Operating profit | -89.07%-11.24M | -51.00%-9.67M | -34.02%-6.76M | -22.72%-23.83M | 1.15%-6.44M | -10.67%-5.95M | -44.04%-6.4M | -63.40%-5.04M | -18.33%-19.42M | -62.04%-6.52M |
| Net non-operating interest income (expenses) | 131.50%450.39K | 138.85%618.19K | 133.95%291.47K | 53.95%907.99K | 144.46%330.04K | -4.79%194.55K | 64.63%258.82K | 19.30%124.58K | 384.65%589.79K | -28.09%135.01K |
| Non-operating interest income | 181.79%631.98K | 137.75%701.76K | 73.78%377.78K | 64.31%1.1M | 122.91%360.99K | 1.51%224.27K | 67.10%295.17K | 100.12%217.39K | 187.72%668.15K | -30.26%161.95K |
| Non-operating interest expense | 864.51%123.21K | 335.65%62.25K | 442.86%66.56K | 130.02%50.13K | 16.93%10.8K | 216.42%12.77K | 231.05%14.29K | 191.93%12.26K | -21.11%21.79K | 71.79%9.24K |
| Total other finance cost | 244.49%58.39K | -3.33%21.33K | -75.47%19.75K | 146.97%139.71K | 13.84%20.15K | 34.88%16.95K | 45.99%22.06K | --80.54K | -31.76%56.57K | -54.72%17.7K |
| Other net income (expenses) | 90.85%-50.15K | 383.94%532.06K | -5,552.57%-10.46M | -1,229.55%-4.02M | -425.90%-3.48M | -138.60%-548.19K | 89.64%-187.38K | 119.33%191.88K | 69.04%-302.64K | 243.80%1.07M |
| Gain on sale of security | 90.83%-50.27K | 383.26%531K | -5,552.57%-10.46M | -1,229.38%-4.03M | -426.49%-3.49M | -138.60%-548.19K | 89.64%-187.46K | 119.55%191.88K | 67.33%-303.07K | 281.08%1.07M |
| Other non-operating income (expenses) | --128 | 1,239.24%1.06K | ---- | 1,108.96%5.13K | 1,119.08%5.05K | ---- | --79 | ---- | 100.85%424 | 100.27%414 |
| Income before tax | -72.11%-10.84M | -34.54%-8.52M | -258.25%-16.93M | -40.85%-26.95M | -80.51%-9.59M | -68.05%-6.3M | -3.85%-6.33M | -18.91%-4.73M | -10.80%-19.13M | -16.11%-5.31M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -72.11%-10.84M | -34.54%-8.52M | -258.25%-16.93M | -40.85%-26.95M | -80.51%-9.59M | -68.05%-6.3M | -3.85%-6.33M | -18.91%-4.73M | -10.80%-19.13M | -16.11%-5.31M |
| Net income continuous operations | -72.11%-10.84M | -34.54%-8.52M | -258.25%-16.93M | -40.85%-26.95M | -80.51%-9.59M | -68.05%-6.3M | -3.85%-6.33M | -18.91%-4.73M | -10.80%-19.13M | -16.11%-5.31M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -72.11%-10.84M | -34.54%-8.52M | -258.25%-16.93M | -40.85%-26.95M | -80.51%-9.59M | -68.05%-6.3M | -3.85%-6.33M | -18.91%-4.73M | -10.80%-19.13M | -16.11%-5.31M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -72.11%-10.84M | -34.54%-8.52M | -258.25%-16.93M | -40.85%-26.95M | -80.51%-9.59M | -68.05%-6.3M | -3.85%-6.33M | -18.91%-4.73M | -10.80%-19.13M | -16.11%-5.31M |
| Diluted earnings per share | -44.44%-0.13 | -22.22%-0.11 | -214.29%-0.22 | 0.00%-0.33 | 22.22%-0.07 | -50.00%-0.09 | 10.00%-0.09 | 0.00%-0.07 | 8.33%-0.33 | 0.00%-0.09 |
| Basic earnings per share | -44.44%-0.13 | -22.22%-0.11 | -214.29%-0.22 | 0.00%-0.33 | 22.22%-0.07 | -50.00%-0.09 | 10.00%-0.09 | 0.00%-0.07 | 8.33%-0.33 | 0.00%-0.09 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.